Philippe Denoël appointed President of the Board of Directors

Congratulations to Philippe Denoël, Head of Vaccines External R&D at GSK, succeeding to Jean Stéphenne to the role of President of the Governing Board of the WEL Research Institute.  

We are grateful to Jean Stéphenne for his insightful governance and spirit of collaborative innovation that shaped the institute since inception. The support from the industry to fundamental research, through Jean's presidency, now taken over by Philippe, is a pillar of our institution.  

Under the leadership of Philippe, and with the continued support of the Walloon region, we are looking forward to seeing  breakthrough discoveries  from our 38 programmes in life sciences (WELBIO), and recently announced 14 programmes in technology (WEL-T), translate into societal impact in health and sustainable transition.

Share this news